Evidence map›Paper›PMID 42357409›Full record

ReviewMolecules (Basel, Switzerland)2026

Quantitative

Shangxiao An, Weiyi Zheng, Qi Tang, Guofang Shen, Yi Wang, Hua Hua, Junning Zhao, Yu Tang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shangxiao AnSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Weiyi ZhengPharmaceutical Informatics Institute, School of Pharmacy, NMPA Center for Innovation and Research in Regulatory Science, Zhejiang University, Hangzhou 310058, China.
Qi TangPharmaceutical Informatics Institute, School of Pharmacy, NMPA Center for Innovation and Research in Regulatory Science, Zhejiang University, Hangzhou 310058, China.
Guofang ShenHangzhou Institute for Food and Drug Control, Hangzhou 310022, China.ORCID 0009-0001-9428-6390
Yi WangPharmaceutical Informatics Institute, School of Pharmacy, NMPA Center for Innovation and Research in Regulatory Science, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-3676-9183
Hua HuaSichuan Institute for Translational Chinese Medicine, Chengdu 610200, China.
Junning ZhaoSichuan Institute for Translational Chinese Medicine, Chengdu 610200, China.
Yu TangPharmaceutical Informatics Institute, School of Pharmacy, NMPA Center for Innovation and Research in Regulatory Science, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0003-1998-3521

Funding

Hangzhou Science and Technology Commission 2025SZD1B15State Administration of Traditional Chinese Medicine of the People's Republic of China 2025YFC3507904State Administration of Traditional Chinese Medicine of the People's Republic of China GZY-KJS-ZJ-2026-077
6 · The paper itself

Abstract

Quantitative

Indexed as

MetabolomicsProton Magnetic Resonance SpectroscopyAnimalsHumansPharmaceutical PreparationsPharmaceutical Preparationsbiomedical analysisdrug analysismetabolomicsquality controlquantitative 1H NMR

Identifiers

PMID42357409
PMCPMC13305634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.